土博士品牌怎么样 申请店铺

我要投票 土博士在兽药行业中的票数:58 更新时间:2024-12-27
土博士是哪个国家的品牌?「土博士」是 重庆永健生物技术有限责任公司 旗下著名品牌。该品牌发源于重庆市,由创始人李 * 旭在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
土博士怎么样

重庆永健生物技术有限责任公司(简称永健生物)位于国家农牧高新技术产业开发区——重庆荣昌高新区,始建于2001年5月,由原四川畜牧兽医学院院长、动物传染病学专家佘永健教授及其弟子们投资创建,2017年12月同华派生物工程集团实现了战略合作,掀开了集团化发展的新篇章。是专业从事兽用精制卵黄抗体及高新生化制剂研发、生产、销售和技术增值服务为一体的技术企业,是国内较早精制蛋黄抗体GMP生产企业。

永健生物现有员工193人,其中教授8人,博士4人,硕士13人,高级兽医师1人,执业兽医师18人,大专以上学历82人。公司拥有土博士动物药品生产厂、SPF实验动物房、现代化高免蛋鸡养殖基地、P3级标准生物实验室、动物疫病诊断中心、生物技术研究所,以及重庆尚上生物技术研究所有限公司和重庆乎文生物技术有限公司。

永健生物坚持自主研发与联合研发相结合,先后与中科院、军事医学科学院、西南大学、南京农大、东北农大、江苏农科院、福建农科院、国家兽用生物制品工程技术研究中心,以及国家动物用保健品工程技术研究中心等科研院校建立了战略合作关系,狠抓新产品开发与市场开拓,产品销售网络不仅遍布全国所有省市,还远销埃塞俄比亚、缅甸、沙特阿拉伯、苏丹等海外多个国家。

永健生物通过近二十载的努力,公司现有精制蛋黄抗体、干扰素、转移因子、中药提取、水针、粉针、口服液、粉(散)剂、预混剂等各种剂型的生物、化学、中草药制剂百余种,已基本形成为现代生态畜牧业畜禽疾病预防保健与治疗药品安全供应和养殖技术咨询服务的保障平台。

大华派、新永健,志存高远,永行永健。我们始终坚持以客户需求为中心,以市场和员工为基本点,以二十多年的抗体研究为基础,多元并举的发展方向,坚守“专业化、规范化、品牌化、信息化”的四化发展道路。永健人始终信奉“科学技术是第一生产力”的精辟论断,矢志以知识创新、技术创新、产品创新、服务创新和管理创新铸百年永健品牌,为全人类的绿色健康养殖事业贡献我们的力量。


Chongqing Yongjian Biotechnology Co., Ltd. (hereinafter referred to as Yongjian Biology) is located in Chongqing Rongchang high tech Industrial Development Zone, a national high tech Industrial Development Zone for agriculture and animal husbandry. It was founded in May 2001 by Professor she Yongjian, the former president of Sichuan Institute of animal husbandry and veterinary medicine and an expert in animal infectious diseases, and his disciples. In December 2017, it realized strategic cooperation with huapai bioengineering group and opened a collection A new chapter in the development of collectivization. It is a technical enterprise specializing in the research and development, production, sales and technical value-added services of refined yolk antibody and high-tech biochemical preparations for animal use, and an earlier GMP manufacturer of refined yolk antibody in China. Yongjian biology has 193 employees, including 8 professors, 4 doctors, 13 masters, 1 senior veterinarian, 18 practicing veterinarians, 82 with college degree or above. The company owns Dr. Tu animal medicine factory, SPF laboratory animal house, modern high immune layer breeding base, P3 standard biological laboratory, animal disease diagnosis center, Biotechnology Research Institute, Chongqing Shangshang Biotechnology Research Institute Co., Ltd. and Chongqing Huwen Biotechnology Co., Ltd. Yongjian biology adheres to the combination of independent R & D and joint R & D, and has successively established strategic cooperation relations with scientific research institutions such as Chinese Academy of Sciences, Academy of Military Medical Sciences, Southwest University, Nanjing Agricultural University, Northeast Agricultural University, Jiangsu Academy of Agricultural Sciences, Fujian Academy of Agricultural Sciences, national animal biological products engineering technology research center, and national animal health care products engineering technology research center, etc., and pays close attention to new products Development and market development, product sales network not only all provinces and cities across the country, but also exported to Ethiopia, Myanmar, Saudi Arabia, Sudan and other overseas countries. Through nearly 20 years' efforts, Yongjian biological has more than 100 kinds of biological, chemical and Chinese herbal medicine preparations, including refined egg yolk antibody, interferon, transfer factor, traditional Chinese medicine extraction, water injection, powder injection, oral liquid, powder (powder) agent, premix, etc., which have basically become the modern ecological animal husbandry animal disease prevention and health care and treatment drug safety supply and breeding technology consultation Service guarantee platform. Dahua school, new Yongjian, has a long-standing ambition and a long way to go. We always adhere to the development direction of taking customer demand as the center, market and employees as the basic points, antibody research for more than 20 years as the basis, multiple and simultaneous development, and adhere to the four development paths of "specialization, standardization, branding and informatization". Yongjian people always believe in the incisive conclusion that "science and technology is the first productivity", and are committed to building a century old Yongjian brand with knowledge innovation, technology innovation, product innovation, service innovation and management innovation, so as to contribute our strength to the green and healthy breeding of the whole mankind.

本文链接: https://brand.waitui.com/616acacb6.html 联系电话:023-46751888,46751999

千城特选小程序码

7×24h 快讯

马斯克自曝转用礼来减肥药:效果优于诺和诺德竞品,副作用更少

埃隆·马斯克周三在社交媒体平台X上透露,他正在使用礼来公司的 Mounjaro来减肥。马斯克在X上发布了一张他打扮成圣诞老人的照片,照片中他站在一棵圣诞树旁,并配文“Ozempic圣诞老人”。马斯克在另一条帖子中表示:“就像可卡因熊(Cocaine Bear),不过这是圣诞老人和Ozempic的组合。”马斯克随后在多条帖子中证实自己确实在使用类似Ozempic的药物来减重。Ozempic是诺和诺德旗下的糖尿病药物。

2小时前

相对吸引力上升,港股红利资产受关注

日前,平安港股通红利优选发布公告称,将原定募集时间截止日2024年12月20日,延长至2024年12月25日。存量红利产品方面,国联安新蓝筹红利一年定开于近期宣布清盘,截至三季度末,该基金规模仅有0.57亿元。业内人士表示,由于红利产品此前密集发行,同质化问题凸显,同类产品竞争激烈,是导致上述现象的主要原因。在投资机会上,港股红利指数具有较好的收益稳定性,近期可以积极关注相关品种。(中证网)

2小时前

看好明年A股,外资公募积极“上新”

2024年临近尾声,外资公募正积极“上新”,为明年的A股投资做准备。富达基金和贝莱德基金近日发布公告称,公司旗下各有一只权益类产品将于明年1月发行。此外,富达低碳成长混合已于今年12月底成立。多家外资机构表示,在企业盈利复苏、股票估值合理、政策工具充足等利好因素的支撑下,明年的A股市场将为主动管理提供有利的投资环境。(上证报)

2小时前

国泰君安:OpenAI提升用户体验,o3模型创新突破

36氪获悉,国泰君安研报表示,OpenAI 12 days发布会最后四天发布了o1 API、o3等最新功能。o1模型通过增强API功能(如函数调用、结构化输出和视觉输入),大幅提升了开发者的效率和应用场景的多样性;o3系列模型则在编码、数学和科学推理等领域展现出接近或超越人类专家的能力,同时通过灵活的推理强度设置,显著降低了使用成本。重点关注以下赛道:AI开发工具与平台(如API服务和SDK支持);AI推理与高性能计算,以及AI安全对齐技术产品。这些领域或将受益于OpenAI的技术突破而得到更多发展机遇。

2小时前

芬兰对涉嫌海底电缆断裂事件的油轮展开调查

芬兰警方26日说,芬兰执法部门正在对一艘油轮展开调查,该油轮可能与25日波罗的海海域连接芬兰和爱沙尼亚的一条海底电缆断裂事件有关。根据芬兰警方发布的新闻通报,海底电缆断裂发生在芬兰专属经济区内。芬兰政府26日在一份新闻公报中说,这一故障暂时不会对芬兰的电力系统构成威胁,短期内对电价的影响不大。(央视新闻)

2小时前

本页详细列出关于碧云天B.Y.T的品牌信息,含品牌所属公司介绍,碧云天B.Y.T所处行业的品牌地位及优势。
咨询